Channelpedia

PubMed 24911002


Referenced in Channelpedia wiki pages of: none

Automatically associated channels: SK1 , TRP , TRPC , TRPC3 , TRPV , TRPV4



Title: A functional transient receptor potential vanilloid 4 (TRPV4) channel is expressed in human endothelial progenitor cells.

Authors: Silvia Dragoni, Germano Guerra, Alessandra Fiorio Pla, Giuseppe Bertoni, Alessandra Rappa, Valentina Poletto, Cinzia Bottino, Adele Aronica, Francesco Lodola, Maria Pia Cinelli, Umberto Laforenza, Vittorio Rosti, Franco Tanzi, Luca Munaron, Francesco Moccia

Journal, date & volume: J. Cell. Physiol., 2015 Jan , 230, 95-104

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/24911002


Abstract
Endothelial progenitor cells (EPCs) are mobilized into circulation to replace damaged endothelial cells and recapitulate the vascular network of injured tissues. Intracellular Ca(2+) signals are key to EPC activation, but it is yet to be elucidated whether they are endowed with the same blend of Ca(2+) -permeable channels expressed by mature endothelial cells. For instance, endothelial colony forming cells (ECFCs), the only EPC subset truly committed to acquire a mature endothelial phenotype, lack canonical transient receptor potential channels 3, 5 and 6 (TRPC3, 5 and 6), which are widely distributed in vascular endothelium; on the other hand, they express a functional store-operated Ca(2+) entry (SOCE). The present study was undertaken to assess whether human circulating EPCs possess TRP vanilloid channel 4 (TRPV4), which plays a master signalling role in mature endothelium, by controlling both vascular remodelling and arterial pressure. We found that EPCs express both TRPV4 mRNA and protein. Moreover, both GSK1016790A (GSK) and phorbol myristate acetate and, two widely employed TRPV4 agonists, induced intracellular Ca(2+) signals uniquely in presence of extracellular Ca(2+). GSK- and PMA-induced Ca(2+) elevations were inhibited by RN-1734 and ruthenium red, which selectively target TRPV4 in mature endothelium. However, TRPV4 stimulation with GSK did not cause EPC proliferation, while the pharmacological blockade of TRPV4 only modestly affected EPC growth in the presence of a growth factor-enriched culture medium. Conversely, SOCE inhibition with BTP-2, La(3+) and Gd(3+) dramatically decreased cell proliferation. These data indicate that human circulating EPCs possess a functional TRPV4 protein before their engraftment into nascent vessels.